Latest News about MRK
Recent news which mentions MRK
Is Gilead Sciences Stock a Buy Now?
December 07, 2021
From Motley Fool
The Daily Biotech Pulse: Acadia Jumps On Data, vTv Shelves Psoriasis Study, More Setbacks For Merck's HIV Program, Decision Day For Daré
December 07, 2021
From Benzinga
3 Dow Stocks Begging to Be Bought in December
December 07, 2021
From Motley Fool
Why Vaccine Stocks Like BioNTech and Novavax Are Crashing Today
December 06, 2021
From Motley Fool
Canada, Merck Ink Supply Pact For 1M Doses Of Molnupiravir For COVID-19
December 06, 2021
Tickers
MRK
From Benzinga
Merck's Keytruda Wins Eighth FDA Approval Of 2021, This Time For Adjuvant, Pediatric Melanoma Settings
December 06, 2021
Tickers
MRK
From Benzinga
The Week Ahead In Biotech (Dec. 6-Dec. 11): Daré FDA Decision, Adcom Tryst For Reata, Multiple Conference Presentations And More
December 06, 2021
From Benzinga
7 Stocks to Buy to Give Your Portfolio a Booster Shot
December 06, 2021
From InvestorPlace
Here's Why Merck Lost Nearly $40 Billion in Value During November
December 04, 2021
From Motley Fool
Will Adagio's COVID Antibody Therapy Be Too Late to the Party?
December 04, 2021
From Motley Fool
Here's Why The New Coronavirus Variant Won't Harm Pfizer's Stock
December 03, 2021
From Motley Fool
Bristol Myers - Merck's Thalassemia Candidate Under FDA Priority Review
December 03, 2021
From Benzinga
The Daily Biotech Pulse: Protagonist Pulls Plug On Phase 1 Asset, Xenon Aces Mid-Stage Epilepsy Study, Esperion Prices Offering
December 03, 2021
From Benzinga
3 Stocks to Buy for the New COVID Variant
December 02, 2021
From Motley Fool
Regeneron: Surfing on Covid, With More Under the Surface
December 02, 2021
From InvestorPlace
Is High Pressure Good for Drug Development?
December 02, 2021
From Benzinga
Attention Biotech Investors: Mark Your Calendar For December PDUFA Dates
December 02, 2021
From Benzinga
Vir Biotech - GSK's COVID-19 Antibody Shows Preclinical Activity Against Omicron Variant
December 02, 2021
From Benzinga
From Benzinga
Market Rollercoaster Continues in Wake of Powell's Comments
December 01, 2021
From Benzinga
2 Ridiculously Cheap Dividend Stocks To Buy for 2022
December 01, 2021
From Motley Fool
U.S. to tighten testing requirements for travelers in light of omicron variant, and analysts expected limited authorization of Merck antiviral
December 01, 2021
From MarketWatch
After high hopes for Merck’s COVID-19 pill, Wall Street now expects a ‘tepid’ authorization
December 01, 2021
From MarketWatch
Merck's Pneumococcal 15-valent Conjugate Vaccine Under Priority FDA Review For Use In Kids
December 01, 2021
Tickers
MRK
From Benzinga
From Benzinga
AdComm Narrowly Backs Merck's COVID-19 Pill, Despite Efficacy Questions
December 01, 2021
From Benzinga
From MarketWatch
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
